Quantcast

Standard & Poor’s Confirms Rating for Gerresheimer

May 12, 2009

DUSSELDORF, Germany, May 12 /PRNewswire-FirstCall/ — The rating agency
Standard & Poor’s has today confirmed the current rating of BB+ for the
Gerresheimer Group and continues to categorize the outlook as stable. The
focus of the MDAX company on the pharma & life science industry is therefore
assessed as positive and sustainable by the rating agency.

About Gerresheimer

Gerresheimer employs around 10,000 people in 42 locations in Europe,
America and Asia. In the financial year 2008, worldwide sales totalled
EUR1.06bn. The product portfolio ranges from pharmaӚ­ceuӚ­tical vials made of
glass and plastic through to complex drug-delivery systems for the pharma &
life science industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and application of medications. The
Group enjoys a leading position in markets which are characterized by high
technical and regulatory barriers.

    Contact Press

    Burkhard Lingenberg
    Director Corporate Communication & Marketing
    Phone +49-211-6181-250
    Fax +49-211-6181-241
    e-mail b.lingenberg@gerresheimer.com

    Contact Investor Relations

    Anke Linnartz
    Director Corporate Investor Relations
    Phone +49-211-6181-314
    Fax +49-211-6181-121
    e-mail a.linnartz@gerresheimer.com

SOURCE Gerresheimer AG


Source: newswire



comments powered by Disqus